Anti-psychotic drug linked to compulsive gambling and other behaviors
The anti-psychotic drug Abilify has been linked to compulsive gambling, shopping, hypersexuality and other risky behaviors, though many in the United States were not aware of those serious side effects due to insufficient warnings given to patients and doctors.
RPWB represents Abilify users nationwide who developed uncontrollable gambling and shopping while taking the drug. Those who experienced these disorders while taking the drug should contact an attorney to discuss their legal rights and the possibility of compensation for gambling losses, healthcare and other expenses.
Even though Abilify’s warning labels in Europe warned patients about pathological gambling since 2012, the drug’s manufacturers omitted this information from labels and patient guides in the United States until 2016.
That means that doctors and patients were not fully aware of the drug’s dangerous side effects when they discussed treatment options, even though the manufacturers, Bristol-Myers and Otsuka Pharmaceutical, had known about them for years.
In the first 13 years Abilify has been on the market in the United States, FDA reporting identified 184 case reports in which there was an association between Abilify use and impulse-control problems. Pathological gambling was the most common (164 cases), but other compulsive behaviors including compulsive eating, spending or shopping, and sexual behaviors were also reported. In the majority of cases, patients with no prior history of the compulsive behaviors experienced uncontrollable urges only after starting treatment.
The manufacturers acknowledged serious reports of pathological gambling in a six-month safety report submitted to the European Medicines Agency in 2011, a full five years before American patients were warned.
From August 2013 to December 2014, the drug companies spent more than $10 million paying doctors to promote Abilify. The companies have spent millions of dollars in direct-to-consumer ads. Promotional materials used by pharmaceutical representatives made no mention of compulsive gambling. In fact, there was no mention of gambling on the drug’s website until January 2016.
In May 2016, the FDA issued a warning that Abilify usage is associated with “compulsive or uncontrollable urges to gamble, binge eat, shop, and have sex.” The previous year, regulators in Canada found an increased risk of pathological (uncontrollable) gambling and hypersexuality with Abilify use.
Bristol-Myers touted Abilify as its “2013 largest-selling product” noting worldwide sales of $2.3 billion. During just a three-month period in 2014, U.S. revenues totaled $417 million. Since its introduction to the United States market, Abilify has generally been used to treat patients with schizophrenia, bipolar disorder, as an adjunct for depression, and autism spectrum disorders.
In 2016, the many Abilify cases filed nationwide were consolidated into what is called a multidistrict litigation, which means that all of the federal cases are moved to a single court so that the process can be streamlined. The cases were consolidated in federal court in the Northern District of Florida in front of Judge M. Casey Rodgers.
On March 13, 2018, Judge Rodgers set trial dates for the first three Abilify lawsuits, which are called bellwether trials. The first case, involving plaintiff Fanny Lyons, will begin on June 18, 2018. The second Abilify lawsuit trial is scheduled for August 6, 2018, involves plaintiffs David Viechec and Cassie Viechec. The third trial on August 27, 2018, involves the Abilify case of Jennifer Lilly. These bellwether trials give attorneys on both sides the opportunity to see how the judge and jurors respond to issues that are common to many of the cases that have been filed to-date.
UPDATE: On 4/30/2018, the parties in the first three bellwether cases reported that they had reached a settlement in all three cases. The parties have indicated that they are working on a global settlement of pending Abilify cases, and are expected to have additional details about the terms of the settlement in the next few months.
Because statutes of limitation might limit the amount of time you have to file a lawsuit, we strongly urge Abilify users who have suffered from compulsive gambling and shopping should contact an attorney to learn about their legal rights.
RPWB represents people throughout the country who developed compulsive behaviors while taking Abilify. Patients and their doctors were not sufficiently warned of the risks, and those who suffered should be compensated.
Our firm is nationally recognized for representing individuals who have been harmed by prescription and non-prescription drugs as well as medical devices. We were named a 2017 Best Law Firm by U.S. News & World Report in the areas of products liability and personal injury litigation. We are a top-listed plaintiff product liability firm as rated by Best Lawyers in America.
RPWB attorneys have been appointed lead counsel in seven large multidistrict litigations and leadership positions in many more. Our team is sensitive to the wishes of our clients yet tenacious and experienced enough to secure maximum compensation.
Our firm has substantial national experience with products liability litigation against drug makers and medical device manufacturers. With respect to pharmaceutical litigation, RPWB attorneys have been appointed lead counsel of seven nationwide multidistrict litigations in recent years. We currently serve or have recently served on various National Plaintiffs’ Steering Committees for consolidated litigation involving: Baycol®, Chantix®, Lipitor®, Ortho Evra®, Phenylpropanolamine (PPA), Rezulin® and Zyprexa®.
Over the years, we have become known for litigating cases against the manufacturers of anti-psychotic drugs. RPWB was in national leadership positions for Chantix and Zyprexa litigation. RPWB was co-lead counsel of Chantix Litigation, which resulted in a $291 million settlement. The Zyprexa litigation settled for $2.1 billion.
Start Your Free Case Review
Give Us A Call
Our Experienced Lawyers
How can we help? Fill out the form for a free case review.
- Toll Free: 888.293.6883
Nov 18, 2020
RPWB is a US News 2021 Best Law Firm
CHARLESTON, S.C. – U.S. News & World Report has named Richardson, Patrick, Westbrook & Brickman as a 2021 Best Law Firm for its work in personal injury, product liability, mass torts, medical malpractice, securities litigation, healthcare law and railroad law. The announcement by U.S. News followed RPWB’s inclusion on the 2021 Best Lawyers in America […]READ MORE
Sep 09, 2020
The chase of PPP fraud is on
When the federal government raced to release more than $2.2 trillion in coronavirus aid earlier this year, it did so knowing that some of that money would go to fraudulent claims. With the money needed immediately by struggling businesses and workers, the government could not efficiently control fraud on the front end, so it was […]READ MORE
Aug 25, 2020
Top-Listed Firm for Personal Injury, Product Liability and Mass Torts
RPWB is the top-listed plaintiff law firm in South Carolina for personal injury, product liability and mass tort litigation in the 2021 edition of The Best Lawyers in America®. In all, 14 RPWB attorneys were named Best Lawyers in their respective practice areas. Two other RPWB lawyers were named “Ones to Watch,” a designation for […]READ MORE
Mar 02, 2020
How are Mesothelioma Lawsuits Paid Out?
By Ken Wilson Some of the most frequent questions we get about mesothelioma lawsuits concern how they are ultimately paid out to clients and how long it will all take. To address those questions, let me give you a little bit of context about how mesothelioma lawsuits work. When a person is diagnosed with mesothelioma, […]READ MORE
Feb 02, 2020
$1.5 Billion Syngenta Corn Farmer Settlement Finalized
Corn Farmer Settlement Checks Are On The Way This week we received some very good news for corn farmers nationwide who suffered price losses associated with the botched launch of genetically-modified corn seed by Syngenta in 2013. On January 3, 2020, the U.S. District Court for the District of Kansas in Kansas City approved a […]READ MORE
Feb 01, 2020
RPWB is a 2020 U.S. News & World Report Best Law Firm
CHARLESTON, S.C. – U.S. News & World Report has named Richardson, Patrick, Westbrook & Brickman as a 2020 Best Law Firm for the firm’s work in personal injury, mass torts and class actions, product liability, medical malpractice, securities litigation, healthcare law and railroad law. U.S. News’ announcement came on the heels of the 2020 Best […]READ MORE
Jan 31, 2020
16 RPWB Lawyers Selected For Best Lawyers List
CHARLESTON – RPWB was once again the top-listed plaintiff law firm in South Carolina for product liability cases as well as mass tort and class action lawsuits in the 2020 edition of The Best Lawyers in America®, which was released in August 2019. In total, 16 RPWB attorneys were designated as 2020 Best Lawyers, including […]READ MORE
Jan 30, 2020
Asbestos causes mesothelioma, and now scientists know why
It is no secret that exposure to asbestos causes cancer. However, while scientists definitively established this link decades ago, the exact mechanism was still a mystery. A recent study apparently demonstrates just how asbestos causes mesothelioma, which at some point in the future could possibly be helpful to doctors in South Carolina who treat patients […]READ MORE
Jan 22, 2020
Study confirms link between cosmetic products and mesothelioma
Wearing makeup and using other cosmetic products is quite common in South Carolina. Unfortunately, just because something is common does not mean it is safe. For example, asbestos contamination is shockingly common in the cosmetics industry. A recent study established a definite link between the deadly cancer mesothelioma and asbestos found in many cosmetic products. […]READ MORE
Jan 18, 2020
FDA pushes for more testing amid asbestos exposure concern
Current asbestos testing standards for industries that use talc are fairly loose. As recent reports have shown that many products contain this toxic substance, the U.S. Food and Drug Administration is pushing for new testing standards. If implemented, it could possibly lower the risk of asbestos exposure for people in South Carolina and across the […]READ MORE
Jan 17, 2020
Is diagnosing mesothelioma difficult?
If you’ve worked in a job that exposed you to asbestos, you may already know the risk for mesothelioma. But when the disease takes years to show up, how do doctors know whether or not you have it? Mesothelioma is a rare disease. And many different illnesses have similar symptoms. To diagnose patients, doctors must […]READ MORE
Jan 15, 2020
How can I find clinical trials for mesothelioma?
If you have mesothelioma from asbestos exposure, you know that only limited treatment exists. However, science is always searching for new ways to treat or cure the disease. If you have exhausted your options for treatment, a clinical trial can test out a new way to fight your mesothelioma. Your doctor may be aware of […]READ MORE
Jan 08, 2020
Asbestos litigation: Johnson & Johnson faces another lawsuit
South Carolina consumers should feel confident that they are making safe purchases, but this is unfortunately more difficult than it seems. Companies are frequently more concerned with their own bottom lines than they are with the health and safety of their customers. Concerned over citizens’ safety, one state is engaging in asbestos litigation against Valeant […]READ MORE
Dec 31, 2019
Construction workers learn of asbestos exposure months later
There is a very good reason that asbestos abatement is tightly regulated in South Carolina. When mishandled, asbestos fibers are released into the air. Those airborne fibers are easily inhaled. For those who do not quite understand just how serious this is, it is important to know that asbestos exposure can lead to a number […]READ MORE
Dec 23, 2019
Miners, construction workers at higher risk for mesothelioma
Asbestos has not disappeared from South Carolina. Whether from old buildings and products or in new uses, asbestos can still be found in many — all over and even in the workplace. Almost anyone could be at risk for exposure, but there are some who face an even greater risk than others. Here are some […]READ MORE